chromID MRSA
FDA 510(k) K162076 · bioMerieux, Inc.
510(k) numberK162076
Submission
- Device name
- chromID MRSA
- Applicant
- bioMerieux, Inc.
Hazelwood, MO, US - Received
- July 27, 2016
- Decision date
- October 25, 2016
- Decision
- Substantially Equivalent (SESE)
- Type
- Traditional 510(k)
- Summary
- 510(k) summary available from FDA
Device classification
- Product code
- JSO – Culture Media, Antimicrobial Susceptibility Test, Excluding Mueller Hinton Agar
- Device class
- Class II (moderate risk)
- Regulation
- 21 CFR 866.1700
- Specialty
- Microbiology
Other 510(k)s with product code JSO
| 510(k) | Device | Applicant | Decision |
|---|---|---|---|
| K190553 | HardyCHROM CREJSO · Traditional | Hardy Diagnostics | 04/29/2019SE |
| K181092 | CHROMID CARBA agar (CARB)JSO · Traditional | Biomerieux S.A. | 07/06/2018SE |
| K171061 | MRSASelect IIJSO · Traditional | Bio-Rad | 12/28/2017SE |
| K162620 | Remel Spectra ESBLJSO · Traditional | Remel, Inc. | 05/01/2017SE |
| K160512 | HardyCHROM ESBLJSO · Traditional | Hardy Diagnostics | 11/15/2016SE |
| K151688 | chromID MRSAJSO · Traditional | bioMerieux, Inc. | 03/11/2016SE |
| K122187 | Vreselect Culture MediumJSO · Traditional | Bio-Rad | 11/06/2012SE |
| K103684 | Vreselect Culture MediumJSO · Traditional | Bio-Rad | 10/21/2011SE |
| K102922 | Hardychrom MrsaJSO · Traditional | Hardy Diagnostics | 05/04/2011SE |
| K100589 | Mrsa Select - Skin and Soft Tissue Wound SpecimensJSO · Traditional | Bio-Rad | 10/29/2010SE |
More from Bio-Rad
| 510(k) | Device | Decision |
|---|---|---|
| K260160 | VITEK REVEAL GN AST Assay and VITEK REVEAL AST SystemSAN · Traditional | 07/08/2026SE |
| K260282 | VITEK 2 AST-Streptococcus Inducible Clindamycin ResistanceLON · Traditional | 04/15/2026SE |
| K260281 | VITEK 2 AST-Streptococcus Cefuroxime (<=0.125 - >=8 µg/mL)LON · Traditional | 03/26/2026SE |
| K251579 | VITEK 2 AST-Gram Negative Cefazolin (=<1-=>32 µg/mL)LON · Traditional | 08/21/2025SE |
| K234012 | Vitek Compact ProLON · Traditional | 03/14/2025SE |
| K232967 | VITEK 2 AST-Yeast Voriconazole (<= 0.03125 - >= 4 µg/mL)NGZ · Traditional | 06/12/2024SE |
| K232963 | VITEK 2 AST-Yeast Anidulafungin (<= 0.015 - >= 8 µg/mL)NGZ · Traditional | 06/07/2024SE |
| K240279 | Vidas Tbi (Gfap, UCH-L1)QAT · Traditional | 05/01/2024SE |
| K234000 | VITEK 2 AST-Gram Positive Lefamulin (<=0.03 - >=4 µg/mL)LON · Traditional | 03/11/2024SE |
| K232201 | VITEK 2 AST-Streptococcus Penicillin (<=0.06 - =>8 µg/mL), VITEK 2 Streptococcus…LON · Traditional | 10/23/2023SE |
Questions and answers
When was chromID MRSA cleared by the FDA?
chromID MRSA (K162076) received a 510(k) decision of Substantially Equivalent on October 25, 2016, 90 days after the submission was received.
What is the product code of K162076?
The FDA product code is JSO – Culture Media, Antimicrobial Susceptibility Test, Excluding Mueller Hinton Agar, a Class II (moderate risk) device regulated under 21 CFR 866.1700.